{
  "report_rows": [
    {
      "kpi": "Core Organic Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~4.5% vs. cons 3.76%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AHS Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$340M vs. cons $333M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.72 vs. cons $0.708",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Adj. EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$3.05 midpoint vs. cons $2.999",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Core Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~3%-4% midpoint vs. cons 3.03%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 EPS qualitative (Q3 2026)",
      "prediction": "LOWER",
      "answer": "guide ~$0.72-$0.74 vs. implied cons ~$0.75",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.5,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 Archetype A history shows front-loaded move; modest estimate revisions (+1-2% FY EPS) provide slight follow-through but no meaningful fade or acceleration",
  "day5_confidence": "MEDIUM"
}